Talen Energy's $1.5 billion buyback meets a 68% jump in short interest as EBITDA nearly doubled

Talen Energy▲+8.94% — Talen Energy, up 8.94 percent today, the Houston independent power producer whose Susquehanna nuclear plant in Pennsylvania is central to its operations as it pursues projects for large-scale electricity users including data centers, reported third-quarter results on November 3, 2026↗, that read like two companies ¹²³. Adjusted EBITDA, the cash proxy management runs on, hit $669 million, up $306 million from $363 million a year earlier, and Adjusted Free Cash Flow rose $210 million to $433 million. ¹²³

GAAP net income went the other way, down $69 million to $138 million↗, as unrealized mark-to-market losses on hedges and interest on acquisition debt ate the operating gains. ¹³

The growth is partly bought, and the market knows it

Talen's Cornerstone acquisition lifted generation to 23.9 terawatt-hours in the quarter from 11.1 a year ago, and capacity revenues more than doubled to $323 million in PJM, the Mid-Atlantic power market where data-center demand is setting prices. ¹ Management introduced 2027 guidance of $2,500 million to $2,850 million in Adjusted EBITDA, about 26% growth at the midpoint versus 2026. ¹

The market is not buying it yet. Short interest jumped 68.2% between September 30 and October 15↗, from 2.50 million to 4.21 million shares, now 8.9% of the company, and shares opened November 2 at $343.12, well below the $458.69 consensus target. ²

The buyback is the squeeze, if PJM holds

Here is the collision. On October 1, Talen took delivery of about 3.8 million retired shares under a $1.5 billion accelerated share repurchase, funded by selling rights to roughly $1.5 billion of future PJM capacity cash flows for $1.3 billion in cash, about 87 cents on the dollar. ¹ A further $1.5 billion remains authorized through 2028. ¹

At the November 2 open of $343.12, that remaining authorization covers roughly 4.4 million shares, more than the entire short position of 4.21 million. ¹² The bear's best fact cuts against the bear: management is monetizing capacity upside at a discount to retire stock today, with more than a third of shares outstanding at emergence already repurchased for about $4.0 billion since 2024. ¹²

Both camps are betting on one document

The squeeze reading assumes the shorts are wrong on direction; nothing in the record says whether the 68% build is a hedge against long exposure or an outright bet against PJM prices, and that question stays open. ² What both camps share is the risk: PJM capacity auction prices set the buyback funding and the 2027 numbers alike. ¹ Final ASR settlement lands by the end of the first quarter of 2027, 3.1 days to cover sits against it. ¹² Watch it. ¹²